Investment case

scroll

Accrol is the market leader in the fastest growing segment of UK consumer soft tissue market, private label (also known as own label).
The UK tissue market is worth £1.6bn (retail sales) and is growing at 2.8%.
Private label sales represent 50% up from 48% last year.
Market is growing by over 8% year on year and sales in traditional big brands are declining by circa 6% year on year.
Accrol has an industry leading product range and a broad customer base – no one customer represents more than 21% of revenue.
The UK soft tissue market is consolidating, improving the opportunity and returns for the strongest players.
The Group is cash generative.
Accrol has a highly experienced and invested management team with proven track record in transformational change, operational excellence and commercial leadership that delivers consistent levels of return.
Accrol has a keen understanding of consumer behaviour, enabling the Group to react quickly to and capitalise on changing trends.
A relentless drive on operational efficiency and input cost management has created the strongest foundations on which to grow.
The business has been fully restructured and is now well invested and operationally efficient with significant headroom for growth.